Should informed consent for cancer treatment include a discussion about hospital outcome disparities?
2008

Should Informed Consent for Cancer Treatment Discuss Hospital Outcome Disparities?

Sample size: 1498 publication Evidence: moderate

Author Information

Author(s): Nadine Housri, Robert J. Weil, David I. Koniaris, Leonidas G. Koniaris

Primary Institution: University of Miami Miller School of Medicine

Hypothesis

Should physicians inform patients about hospital outcome disparities for certain cancers during the informed consent process?

Conclusion

Physicians have an ethical obligation to inform patients of hospital outcome disparities for select cancers.

Supporting Evidence

  • Higher hospital procedure volume is associated with better surgical outcomes.
  • Patients often receive information about hospital disparities from various sources, not just their doctors.
  • Informed consent should include discussions about where to receive treatment based on outcome data.

Takeaway

Doctors should tell patients if some hospitals do better than others for cancer surgeries, so patients can make better choices.

Methodology

The debate reviews existing literature on hospital volume and patient outcomes in cancer surgeries.

Potential Biases

There may be a risk of hospitals manipulating data to improve their perceived outcomes.

Limitations

The study does not address how to effectively communicate complex outcome data to patients.

Participant Demographics

Patients undergoing cancer surgeries across various hospitals.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.pmed.0050214

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication